Loading chat...
NJ A1526
Bill
Status
1/9/2024
Primary Sponsor
Gerard Scharfenberger
Click for details
AI Summary
-
Classifies xylazine and its various compounds as a Schedule III controlled dangerous substance in New Jersey, with an exemption for veterinarians using it in the professional practice of veterinary medicine
-
Makes illegal manufacture, distribution, or dispensing of xylazine a third-degree crime punishable by 3-5 years imprisonment and fines up to $25,000
-
Establishes possession, use, or being under the influence of xylazine as a third-degree crime with fines up to $35,000
-
Provides enhanced penalties for xylazine offenses committed within 1,000 feet of school property, within 500 feet of certain public spaces, or when distributed to minors or pregnant persons
-
Directs the Director of the Division of Consumer Affairs to promulgate rules and regulations to implement the new classification
Legislative Description
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
Judiciary
Last Action
Introduced, Referred to Assembly Judiciary Committee
1/9/2024